Regulation of Adipogenesis and Key Adipogenic Gene Expression by 1, 25-Dihydroxyvitamin D in 3T3-L1 Cells

Abstract

The functions of 1, 25-dihydroxyvitamin D (1, 25-(OH)2D3) in regulating adipogenesis, adipocyte differentiation and key adipogenic gene expression were studied in 3T3-L1 preadipocytes. Five concentrations (0.01, 0.1, 1, 10, 100nM) of 1, 25-(OH)2D3 were studied and lipid accumulation measured by Oil Red O staining and expression of adipogenic genes quantified using quantitative real-time PCR. Adipogenic responses to 1, 25-(OH)2D3 were determined on 6, and 12 h, and days 1-10 after induction of adipogenesis by a hormonal cocktail with or without 1, 25-(OH)2D3. In response to 1, 25-(OH)2D3 (1, 10, and 100 nM), lipid accumulation and the expression of PPARγ, C/EBPα, FABP4 and SCD-1 were inhibited through day 10, and vitamin D receptor expression was inhibited in the early time points. The greatest inhibitory effect was upon expression of FABP4. Expression of SREBP-1c was only affected on day 2. The lowest concentrations of 1, 25-(OH)2D3 tested did not affect adipocyte differentiation or adipogenic gene expression. The C/EBPα promoter activity response to 1, 25-(OH)2D3 was also tested, with no effect detected. These results indicate that 1, 25-(OH)2D3 inhibited adipogenesis via suppressing adipogenic-specific genes, and is invoked either during PPARγ activation or immediately up-stream thereof. Gene expression down-stream of PPARγ especially FABP4 was strongly inhibited, and we suggest that the role of 1, 25-(OH)2D3 in regulating adipogenesis will be informed by further studies of adipogenic-specific gene promoter activity.

Nutrigenomic regulation of adipose tissue development — role of retinoic acid: A review

“…2b). These notions were confirmed by a recent study in the inhibitory effect of vitamin D on adipogenesis (Ji, Doumit, & Hill, 2015). …”

Histone macroH2A1.2 promotes metabolic health and leanness by inhibiting adipogenesis

“…Our in silico analysis of TF-binding sites in proximity of macroH2A1.2 genome binding revealed that GATA-binding sites were overrepresented in the proximity of macroH2A1.2 binding in 3T3-L1 pre-adipocytes compared to differentiated cells, consistent with their role in adipocyte precursors and with their downregulation setting the stage for terminal differentiation. In mature adipocytes, RXRA::VDR and TP53-binding sites were enriched, which might reflect their anti-adipogenic transcriptional effects [33, 34]. The enrichment of consensus sequences for TF controlling homeobox genes, including the overrepresented PAX4, in macroH2A1.2 associates chromatin reads in the context of adipocyte differentiation deserves further investigation.…”

LC/MS-QToF Profiling, Anti-Diabetic and Anti-Adipogenic potential of Divya MadhuKalp: A Novel Herbo-mineral Formulation

“…Obesity is closely associated with diabetes mellitus and characterized by excessive growth of adipose tissue mass because of hyperplasia and hypertrophy of adipocytes. Inhibition of pre-adipocytes differentiation is one of the key therapeutic strategies to inhibit adipogenesis 3,4,5 . Our results showed that DMK significantly suppressed the adipogenic differentiation, lipid content and intracellular triglycerides in 3T3 L1 cells.…”

“…Adipogenesis involves differentiation of pre-adipocytes into mature adipocytes and is regulated by two major adipogenic transcription factors namely, Peroxisome proliferator–activated receptor γ (PPARγ) and CCAAT/enhancer binding protein α (C/EBPα) and downstream induction of adipocyte-related genes including, adipocyte protein 2 (AP2), lipoprotein lipase (LPL), adiponectin etc. 3, 4, 5 .…”